Schantz, Stimson
New York Eye and Ear Infirmary of Mount Sinai,
United States
2023 Rank: 67147
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Otorhinolaryngology
Rank in SubField 1: 2805 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 67147 | 72424 |
| Total Cites | 9772 | 11003 |
| H-index | 54 | 57 |
| Hm-index | 19 | 20 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 68 | 69 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 1208 | 1282 |
| Number of Single+First+Last Authored Papers | 111 | 111 |
| Total Cites to Single+First+Last Authored Papers | 3750 | 4041 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8187 | 8818 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.25 |
| Self-Citation Percentage |
11.19%
|
|
Schantz, Stimson
New York Eye and Ear,
United States
2022 Rank: 62038
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Otorhinolaryngology
Rank in SubField 1: 2624 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 62038 | 68037 |
| Total Cites | 9276 | 10471 |
| H-index | 52 | 54 |
| Hm-index | 19 | 20 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 67 | 68 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 1170 | 1244 |
| Number of Single+First+Last Authored Papers | 112 | 112 |
| Total Cites to Single+First+Last Authored Papers | 3619 | 3910 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7759 | 8376 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.25 |
| Self-Citation Percentage |
11.41%
|
|
Schantz, Stimson
Department of Otolaryngology, New York Eye and Ear,
United States
2021 Rank: 60827
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Otorhinolaryngology
Rank in SubField 1: 2584 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 60827 | 68201 |
| Total Cites | 8967 | 10126 |
| H-index | 51 | 53 |
| Hm-index | 19 | 19 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 66 | 67 |
| Number of Single+First Authored Papers | 48 | 48 |
| Total Cites to Single+First Authored Papers | 1127 | 1200 |
| Number of Single+First+Last Authored Papers | 111 | 111 |
| Total Cites to Single+First+Last Authored Papers | 3505 | 3790 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7492 | 8093 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.25 |
| Self-Citation Percentage |
11.45%
|
|
Schantz, Stimson
New York Eye and Ear Infirmary,
United States
2020 Rank: 57312
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Otorhinolaryngology
Rank in SubField 1: 2548 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 57312 | 61970 |
| Total Cites | 8406 | 9539 |
| H-index | 49 | 52 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 65 | 66 |
| Number of Single+First Authored Papers | 48 | 48 |
| Total Cites to Single+First Authored Papers | 1089 | 1161 |
| Number of Single+First+Last Authored Papers | 111 | 111 |
| Total Cites to Single+First+Last Authored Papers | 3352 | 3639 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7007 | 7597 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.26 |
| Self-Citation Percentage |
11.88%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.